Soliris 300 mg/30 mL (10 mg/mL) injection Images
Generic Name: eculizumab
This medication has been identified as Soliris 300 mg/30 mL (10 mg/mL) injection. It is supplied by Alexion Pharmaceuticals Inc.
Soliris is used in the treatment of Myasthenia Gravis; Neuromyelitis Optica Spectrum Disorder; Hemolytic Uremic Syndrome; Paroxysmal Nocturnal Hemoglobinuria and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Soliris 300 mg/30 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Soliris
- Generic Name
- eculizumab
- Strength
- 300 mg/30 mL (10 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alexion Pharmaceuticals Inc.
- National Drug Code (NDC)
- 25682-0001
More about Soliris (eculizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.